GeneDx Holdings Corp. Capital Expenditures Incurred but Not yet Paid
GeneDx Holdings Corp. (WGS) reported Capital Expenditures Incurred but Not yet Paid of $3.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-03
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$2.76M, a 177.67% decline year-over-year.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $5.92M, a 169.23% increase year-over-year.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $1.81M.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$1.28M, a 160.63% decline year-over-year.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for fiscal 2025 was $6.29M, a 142.05% increase from fiscal 2024.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for fiscal 2024 was $2.60M, a 1838.06% increase from fiscal 2023.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for fiscal 2023 was $134.00K.
- GeneDx Holdings Corp. capital expenditures incurred but not yet paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.15M 10-Q · filed 2026-08-03 | $4.97M derived: sum of 3 quarters · filed 2026-08-03 | $3.69M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $5.92M 10-Q · filed 2026-05-04 | $7.73M derived: sum of 2 quarters · filed 2026-05-04 | $6.45M derived: sum of 3 quarters · filed 2026-05-04 | $10.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $534.00K derived: sum of 2 quarters · filed 2026-02-23 | $4.09M derived: sum of 3 quarters · filed 2026-08-03 | $6.29M 10-K · filed 2026-02-23 |
| 2025-09-30 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.27M derived: sum of 2 quarters · filed 2026-08-03 | $4.47M 10-Q · filed 2025-10-28 | $4.46M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $5.75M 10-Q · filed 2026-08-03 | $5.74M derived: sum of 3 quarters · filed 2026-08-03 | $7.85M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $2.20M 10-Q · filed 2026-05-04 | $2.18M derived: sum of 2 quarters · filed 2026-05-04 | $4.29M derived: sum of 3 quarters · filed 2026-05-04 | $4.76M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.10M derived: sum of 2 quarters · filed 2026-02-23 | $2.56M derived: sum of 3 quarters · filed 2026-02-23 | $2.60M 10-K · filed 2026-02-23 |
| 2024-09-30 | $2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.58M derived: sum of 2 quarters · filed 2025-10-28 | $2.61M 10-Q · filed 2025-10-28 | $1.53M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $465.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $501.00K 10-Q · filed 2025-07-29 | -$585.00K derived: sum of 3 quarters · filed 2026-02-23 | $526.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $36.00K 10-Q · filed 2025-04-30 | -$1.05M derived: sum of 2 quarters · filed 2026-02-23 | $61.00K derived: sum of 3 quarters · filed 2026-02-23 | -$903.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $25.00K derived: sum of 2 quarters · filed 2026-02-23 | -$939.00K derived: sum of 3 quarters · filed 2026-02-23 | $134.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $147.00K derived: sum of 2 quarters · filed 2024-10-29 | $1.22M 10-Q · filed 2024-10-29 | -$326.00K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | -$964.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $109.00K 10-Q · filed 2024-07-30 | -$1.44M derived: sum of 3 quarters · filed 2024-07-30 | -$3.13M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $1.07M 10-Q · filed 2024-04-29 | -$473.00K derived: sum of 2 quarters · filed 2024-04-29 | -$2.17M derived: sum of 3 quarters · filed 2024-04-29 | -$252.00K derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$3.24M derived: sum of 2 quarters · filed 2024-02-23 | -$1.32M derived: sum of 3 quarters · filed 2024-02-23 | $0.00 10-K · filed 2024-02-23 |
| 2022-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $221.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.55M 10-Q · filed 2023-11-03 | $2.11M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.24M 10-Q · filed 2023-08-08 | $3.81M derived: sum of 3 quarters · filed 2023-08-08 | $3.92M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.32M 10-Q · filed 2023-05-09 | $1.89M derived: sum of 2 quarters · filed 2023-05-09 | $2.00M derived: sum of 3 quarters · filed 2023-05-09 | $922.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $568.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $674.00K derived: sum of 2 quarters · filed 2023-03-16 | -$403.00K derived: sum of 3 quarters · filed 2023-03-16 | $761.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$971.00K derived: sum of 2 quarters · filed 2022-11-14 | $193.00K 10-Q · filed 2022-11-14 | $372.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $87.00K 10-Q · filed 2022-08-15 | $266.00K derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $1.16M 10-Q · filed 2022-05-12 | $1.34M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $447.00K 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $268.00K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $818.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |